GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO.NS
Sector
Location
Market Cap
USD 6.12 B
Share Price
USD 36.16
Avg Daily Volume
165,882
Change (1 day)
-0.81%
Change (1 year)
10.88%
Change (YTD)
37.45%
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2025: USD 150.95 M
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow is USD 150.95 M for the year ending March 31, 2025, a 116.32% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2024 was USD 69.78 M, a 18.44% change year over year.
-
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2023 was USD 58.92 M, a -44.82% change year over year.
-
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2022 was USD 106.78 M, a 35.28% change year over year.
-
GlaxoSmithKline Pharmaceuticals Limited Operating Cash Flow for the year ending March 31, 2021 was USD 78.93 M, a 21.26% change year over year.
StockViz
Competitors
Grasim Industries Limited
USD 31.33
GRASIM.NS
-0.12
-0.39%
Siemens Limited
USD 34.65
SIEMENS.NS
-0.37
-1.05%
ABB India Limited
USD 63.13
ABB.NS
-0.20
-0.32%
Dr. Reddy's Laboratories Limited
USD 14.50
DRREDDY.NS
-0.24
-1.60%
Pfizer Limited
USD 59.31
PFIZER.NS
-0.67
-1.12%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|